Attys Agree To $143M Fee Split In $2.3B Avandia MDL
By Juan Carlos Rodriguez (January 22, 2013, 7:19 PM EST) -- Plaintiffs' attorneys on Thursday filed a plan in Pennsylvania federal court to split $143 million to resolve a fee dispute in what could be a $2.3 billion settlement in a massive multidistrict litigation over GlaxoSmithKline PLC's alleged failure to warn consumers about health risks related to its diabetes drug Avandia.
The judge overseeing the case had appointed a committee of eight attorneys who had worked on the case to come up with a fee allocation plan for the 58 lawyers and firms who had earned some amount of compensation for their work. The judge set the total amount to be distributed...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!